MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.
Our research group has two primary focuses. One part of the lab focuses on determining the mechanisms of intracellular ion and metabolite transport, while the second studies protein nucleic acid ...
A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...
Thursday, January 30, 2025 - 4:00 p.m. to 4:30 p.m.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Kimberly Feigin, MD, has been named Chief of the Breast Imaging Service within the Department of Radiology. Dr. Feigin has ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Tuesday, January 28, 2025 - 10:00 a.m. to 11:00 a.m.
Neuro-oncologist Dr. Adrienne Boire discusses her path to becoming a cancer researcher, and on the parallel between science and another passion — knitting.
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback